301180-05-2 Usage
Uses
Used in Pharmaceutical Synthesis:
3-Piperidinecarboxylic acid T-butyl ester HCl is used as a building block for the synthesis of various pharmaceutical products due to its ability to be incorporated into complex molecular structures, contributing to the development of new drugs.
Used in Agrochemical Production:
In the agrochemical industry, 3-Piperidinecarboxylic acid T-butyl ester HCl is used as a key component in the synthesis of pesticides and other crop protection agents, leveraging its reactivity and structural properties to enhance the effectiveness of these products.
Used as a Catalyst in Organic Reactions:
3-Piperidinecarboxylic acid T-butyl ester HCl functions as a catalyst to accelerate specific organic reactions, improving the efficiency and selectivity of chemical processes in both research and industrial applications.
Used as a Chiral Auxiliary in Asymmetric Synthesis:
3-PIPERIDINECARBOXYLIC ACID T-BUTYL ESTER HCL is utilized as a chiral auxiliary in asymmetric synthesis, aiding in the production of enantiomerically pure compounds, which is crucial for the development of pharmaceuticals with specific biological activities.
Used in the Protection of Carboxylic Acid Functionality:
The t-butyl ester group in 3-Piperidinecarboxylic acid T-butyl ester HCl provides protection for the carboxylic acid during chemical reactions, allowing for selective reactions to occur and facilitating the synthesis of drug molecules with desired properties.
Check Digit Verification of cas no
The CAS Registry Mumber 301180-05-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,1,1,8 and 0 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 301180-05:
(8*3)+(7*0)+(6*1)+(5*1)+(4*8)+(3*0)+(2*0)+(1*5)=72
72 % 10 = 2
So 301180-05-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H19NO2/c1-10(2,3)13-9(12)8-5-4-6-11-7-8/h8,11H,4-7H2,1-3H3
301180-05-2Relevant articles and documents
Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
-
Page 117, (2010/02/07)
The present invention relates to novel cinnamide compounds that are useful for treating inflammatory and immune diseases and cerebral vasospasm, to pharmaceutical compositions containing these compounds, and to methods of inhibiting inflammation or suppressing immune response in a mammal.
